J&J Units Sue Nova Over Alleged Patent Infringement
Two Johnson & Johnson subsidiaries have sued Nova Pharmaceuticals Australasia over two treatments that allegedly infringe a patent of one of the units, Actelion, claiming the rival threatened to market and...To view the full article, register now.
Already a subscriber? Click here to view full article